Details of the Metabolic Reaction (MR)

General Information of This Metabolic Reaction (MR) (ID: MR008513)
Formula Reactant AP26113 Product BGB486
Reactant Info Product Info
Metabolic Type Multi-steps Reaction - N-Dealkylation; loss of N-methyl piperazine ring
Other MR(s) Related to The Reactant of This MR
Other MR(s) That Metabolize The Reactant of This MR
MR ID Reactant Product MR Type Related Drug REF
MR008510 AP26113 AP26123 Multi-steps Reaction - N-demethylation; cysteine conjugation AP26113 [1]
MR008512 AP26113 BGB570 Oxidation - N-Demethylation AP26113 [2]
MR008514 AP26113 BGB598 Oxidation - A-Oxidation AP26113 [2]
MR008511 AP26113 BGB600 Oxidation - A-Hydroxylation AP26113 [2]
Other MR(s) Related to The Product of This MR
Other MR(s) That Produce The Product of This MR
MR ID Reactant Product MR Type Related Drug REF
MR000445 Brigatinib BGB486 Unclear Brigatinib [1]
References
1 Brigatinib: first global approval. Drugs. 2017 Jul;77(10):1131-1135.
2 LC-ESI-MS/MS reveals the formation of reactive intermediates in brigatinib metabolism: elucidation of bioactivation pathways

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.